AH, alcohol-Associated hepatitis; ALD, Alcohol-associated liver disease; ASK-1, Apoptosis signal-regulating kinase-1; AUD, alcohol use disorder; CCL2, C­C chemokine ligand type 2; CVC, Cenicriviroc; ELAD, Extracorporeal liver assist device; FMT, Fecal Microbiota Transplant; G-CSF, Granulocyte colony-stimulating factor; HA35, Hyaluronic Acid 35KD; IL-1, interleukin 1; IL-6, interleukin 6; LCFA, saturated long-chain fatty acids; LDL, low-density lipoprotein cholesterol; LPS, Lipopolysaccharides; MCP-1, monocyte chemoattractant protein −1; MDF, Maddrey's discriminant function; MELD, Model for end-stage disease; NAC, N-acetylcysteine; NLRs, nucleotide-binding oligomerization domain-like receptors; PAMPs, Pathogen-associated molecular patterns; RCT, Randomized controlled trial; SAM, S-Adenosyl methionine; SCFA, short-chain fatty acids. 5; TLRs, Toll-like receptors; TNF, tumor necrotic factor; alcohol-associated hepatitis; anti-inflammatory; antioxidants; liver-gut axis; microbiome; sAH, severe alcohol-associated hepatitis